Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Neurology. 2012 Mar 13;78(11):811-5. doi: 10.1212/WNL.0b013e318249f6dc. Epub 2012 Feb 29.
The determinants of subarachnoid hemorrhage (SAH) volume and an atypical pattern of blood are not clear. Our objective was to determine if reduced platelet activity on admission and abnormal venous drainage are associated with greater SAH volume.
We prospectively identified noncomatose patients with SAH without an identifiable aneurysm. We routinely measured platelet activity on admission and recorded aspirin use. SAH volumes were calculated with a validated technique. CT angiograms were reviewed by a certified neuroradiologist for venous drainage. Patients were followed for clinical outcomes through 3 months with the modified Rankin Scale (mRS). Data are Q1-Q3.
There were 31 patients in the cohort. Thirty (97%) underwent an angiogram on admission, and 25 (81%) an additional delayed angiogram. SAH volume was lowest with normal venous drainage bilaterally (4.4 [3.7-16.4] mL) and higher with 1 (12.9 [3.7-20.4]) or 2 (20.9 [12.5-34.6] mL, p = 0.03) discontinuous venous drainages. Patients with reduced platelet activity had more SAH on the diagnostic CT (17.5 [10.6-20.9] vs 6.1 [2.3-15.3] mL) (p = 0.046). SAH volume was greater for patients requiring drainage for hydrocephalus (16.4 [11.5-20.5] vs 5.4 [2.7-16.4] mL) (p = 0.009). Outcomes at 3 months were generally excellent (median mRS = 0, no symptoms).
Discontinuous venous drainage and reduced platelet activity were associated with increased SAH volume and hydrocephalus. These factors may explain thick SAH and reduce the need for repeated invasive imaging in such patients.
蛛网膜下腔出血(SAH)量和非典型血液模式的决定因素尚不清楚。我们的目的是确定入院时血小板活性降低和异常静脉引流是否与更大的 SAH 量有关。
我们前瞻性地确定了没有可识别动脉瘤的非昏迷 SAH 患者。我们常规测量入院时的血小板活性并记录阿司匹林的使用情况。使用验证技术计算 SAH 量。通过认证的神经放射学家对 CT 血管造影进行静脉引流评估。通过改良 Rankin 量表(mRS)对患者在 3 个月内的临床结果进行随访。数据为 Q1-Q3。
队列中有 31 名患者。30 名(97%)在入院时进行了血管造影,25 名(81%)进行了额外的延迟血管造影。双侧正常静脉引流时 SAH 量最低(4.4[3.7-16.4]mL),1 个(12.9[3.7-20.4]mL)或 2 个(20.9[12.5-34.6]mL,p=0.03)不连续静脉引流时 SAH 量更高。血小板活性降低的患者诊断 CT 上的 SAH 更多(17.5[10.6-20.9]vs 6.1[2.3-15.3]mL)(p=0.046)。需要引流脑积水的患者 SAH 量更大(16.4[11.5-20.5]vs 5.4[2.7-16.4]mL)(p=0.009)。3 个月时的结果通常很好(中位数 mRS=0,无症状)。
不连续的静脉引流和血小板活性降低与 SAH 量增加和脑积水有关。这些因素可能解释了厚的 SAH,并减少了此类患者对重复侵入性成像的需求。